Covered recipient · General Payments record
SUPRIYA RASTOGI
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2020–2024
$1,734.90
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,263.64 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $300.26 | 3 |
| ABBVIE INC. | $238.02 | 10 |
| Janssen Biotech, Inc. | $160.15 | 3 |
| GENZYME CORPORATION | $124.24 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $117.26 | 1 |
| UCB, Inc. | $89.47 | 1 |
| Lilly USA, LLC | $62.32 | 3 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $51.83 | 1 |
| Incyte Corporation | $43.89 | 2 |
| Regeneron Healthcare Solutions, Inc. | $32.94 | 1 |
| Arcutis Biotherapeutics, Inc. | $21.83 | 1 |
| FIDIA PHARMA USA INC. | $21.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.89 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383781 | CMS |
| ABBVIE INC. | $24.60 | 10/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383785 | CMS |
| ABBVIE INC. | $17.90 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383789 | CMS |
| ABBVIE INC. | $19.43 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383793 | CMS |
| ABBVIE INC. | $33.21 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383797 | CMS |
| ABBVIE INC. | $22.50 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383801 | CMS |
| ABBVIE INC. | $25.89 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383805 | CMS |
| ABBVIE INC. | $24.22 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383809 | CMS |
| ABBVIE INC. | $22.05 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383813 | CMS |
| ABBVIE INC. | $22.33 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383817 | CMS |
| Amgen Inc. | $139.91 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117662795 | CMS |
| Amgen Inc. | $139.91 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117662797 | CMS |
| Amgen Inc. | $20.44 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117662799 | CMS |
| Arcutis Biotherapeutics, Inc. | $21.83 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121075195 | CMS |
| Fidia Pharma USA Inc. | $21.43 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141158567 | CMS |
| GENZYME CORPORATION | $124.24 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139902524 | CMS |
| Incyte Corporation | $23.52 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141307961 | CMS |
| Incyte Corporation | $20.37 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141196939 | CMS |
| Janssen Biotech, Inc. | $130.01 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078448135 | CMS |
| Janssen Biotech, Inc. | $24.43 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078445365 | CMS |
| Janssen Biotech, Inc. | $5.71 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078443486 | CMS |
| Lilly USA, LLC | $15.09 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135430477 | CMS |
| Lilly USA, LLC | $22.62 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135430479 | CMS |
| Lilly USA, LLC | $24.61 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135420927 | CMS |
| Novartis Pharmaceuticals Corporation | $117.26 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087322935 | CMS |
| Regeneron Healthcare Solutions, Inc. | $32.94 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114143951 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $51.83 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152205811 | CMS |
| UCB, Inc. | $89.47 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143075742 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.